Senseonics Holdings, Inc. Common Stock (SENS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Senseonics Holdings, Inc. Common Stock (SENS) has a cash flow conversion efficiency ratio of -0.202x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-15.82 Million) by net assets ($78.17 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Senseonics Holdings, Inc. Common Stock market capitalisation for the company's overall valuation and market capitalisation.
Senseonics Holdings, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Senseonics Holdings, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Senseonics Holdings, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Senseonics Holdings, Inc. Common Stock ranked by their cash flow conversion efficiency. Explore SENS cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aviva PLC
LSE:AV
|
0.483x |
|
E. W. Scripps Co Class A
NASDAQ:SSP
|
0.135x |
|
Meter Instruments Co. Ltd
SHE:301006
|
0.029x |
|
Bank Ochrony Środowiska SA
WAR:BOS
|
0.047x |
|
Westwing Group AG
F:WEW
|
N/A |
|
I-Sheng Electric Wire & Cable Co Ltd
TW:6115
|
-0.007x |
|
Falcon's Beyond Global, Inc. Class A Common Stock
NASDAQ:FBYD
|
-0.672x |
|
M3-Brigade Acquisition V Corp. Units
NASDAQ:MBAVU
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Senseonics Holdings, Inc. Common Stock (2013–2024)
The table below shows the annual cash flow conversion efficiency of Senseonics Holdings, Inc. Common Stock from 2013 to 2024. View Senseonics Holdings, Inc. Common Stock (SENS) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-16.55 Million | $-60.47 Million | 3.652x | +286.34% |
| 2023-12-31 | $35.80 Million | $-70.16 Million | -1.960x | -107.61% |
| 2022-12-31 | $-2.58 Million | $-66.31 Million | 25.742x | +8416.86% |
| 2021-12-31 | $-185.53 Million | $-56.08 Million | 0.302x | -35.41% |
| 2020-12-31 | $-144.08 Million | $-67.42 Million | 0.468x | -97.03% |
| 2019-12-31 | $-8.65 Million | $-136.05 Million | 15.730x | +1334.89% |
| 2018-12-31 | $71.26 Million | $-90.77 Million | -1.274x | +83.39% |
| 2017-12-31 | $7.27 Million | $-55.74 Million | -7.670x | -198.40% |
| 2016-12-31 | $-4.88 Million | $-38.02 Million | 7.795x | +196.83% |
| 2015-12-31 | $-9.70 Million | $-25.46 Million | 2.626x | +207.84% |
| 2014-12-31 | $7.91 Million | $-19.27 Million | -2.435x | +99.90% |
| 2013-12-31 | $7.08K | $-17.17 Million | -2424.375x | -- |
About Senseonics Holdings, Inc. Common Stock
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabet… Read more